Loading organizations...
STARmed develops and manufactures advanced medical devices focused on radiofrequency and thermal ablation technologies. The company specializes in creating generators and electrodes that enable minimally invasive procedures for various medical conditions. Their technical approach centers on providing precise, image-guided solutions designed to enhance the efficacy and safety of thermal ablation treatments.
Established in 2009, STARmed originated in South Korea with an aim to significantly advance medical treatment options. The founders sought to address the need for less invasive interventions that could improve patient outcomes and provide clinicians with more reliable tools for thermal ablation. This foundational insight drove the company to become a developer of specialized systems for this therapeutic area.
The company's products are utilized by medical professionals globally, serving patients who benefit from targeted, minimally invasive therapeutic interventions. STARmed's vision is to improve the quality of life for patients by continually innovating in thermal ablation, reducing discomfort and offering physicians greater confidence in their ability to treat a range of conditions effectively.
STARmed has 1 tracked investment across 1 company. The latest tracked deal is $2.0M Seed in Theromics in January 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 20, 2022 | Theromics | $2.0M Seed | — | Beacon Angels, John Brooks |